| Literature DB >> 32286405 |
Aline de Freitas Brito1,2, Alexandre Sérgio Silva3,4,5, Caio Victor Coutinho de Oliveira6, Alesandra Araújo de Souza7, Paula Benvindo Ferreira8, Iara Leão Luna de Souza9, Layanne Cabral da Cunha Araujo10, Gustavo da Silva Félix3, Renata de Souza Sampaio6, Renata Leite Tavares11, Reabias de Andrade Pereira3, Manoel Miranda Neto5,11, Bagnólia Araújo da Silva8,12.
Abstract
The purpose of this study was to evaluate the effects of Spirulina Platensis supplementation on selected blood markers of oxidative stress, muscle damage, inflammation, and performance in trained rats. Rats (250 g - 300 g) were submitted to a strength training program (eight weeks), divided into four groups: control (GT) (trained without supplementation), trained with daily-supplementation of 50 mg/kg (GT50), 150 mg/kg (GT150) and 500 mg/kg (GT500). Training consisted of a jump protocol in PVC-cylinder containing water, with increasing load over experimental weeks. We evaluated the markers of oxidative stress (malondialdehyde - MDA and antioxidant capacity) and inflammation (C-reactive protein) at the end of the training. Among groups submitted to strength training, concentration of C-reactive protein decreased after 8 weeks of intervention in the trained group and GT500. Strength training enhanced plasma MDA concentration of malondialdehyde with supplementation of S. platensis in GT150 and GT500. In plasma analysis, strength training enhanced the percentage of oxidation inhibition, with spirulina supplementation in rates of 150 and 500 mg/kg. Spirulina supplementation for 8 weeks (in a dose-effect manner) improved antioxidant capacity as well as attenuated exercise-induced increases in ROS and inflammation. As a practical application, the use as high doses did not cause a reduction in positive physiological adaptations to exercise training. Additional studies are necessary to test the application of Spirulina Platensis in other contexts, as collective sports (basketball, football, soccer).Entities:
Mesh:
Substances:
Year: 2020 PMID: 32286405 PMCID: PMC7156748 DOI: 10.1038/s41598-020-63272-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
experimental design of the strength training protocol.
| Adaptation | Weeks | |||
|---|---|---|---|---|
| 1st and 2nd | 3rd and 4th | 5th and 6th | 7th and 8th | |
| 2–4 sets x 5–9 jumps (50%) | 4 sets x 10 jumps (50%) | 4 sets x 10 jumps (60%) | 4 sets x 10 jumps (80%) | 4 sets x 12 jumps (80%) |
Figure 1C-reactive protein after eight weeks of exercise for the groups () GT () and GT50 (), GT150 () and GT500 (). Vertical columns and bars represent mean and standard deviation, respectively (n = 8). “Two-way” ANOVA followed by Bonferroni post-test. *p ≤ 0.05 GT vs. GT500; #p ≤ 0.05 GT50 vs. GT500; †p ≤ 0.05 GT150 vs. GT500.
Figure 3Antioxidant activity percentage in blood plasma (A), liver (B) and quadriceps (C) obtained after eight weeks of treatment GT () and GT50 (), GT150 () and GT500 (). Vertical columns and bars represent mean and standard deviation, respectively (n = 8).*p ≤ 0.05; GT vs. GT150; GT vs. GT500; #p ≤ 0.05; GT50 vs. GT150; GT50 vs. GT500; †p < 0.01; GT150 vs. GT500.
Figure 2Malondialdehyde concentration in blood plasma (A), liver (B) and quadriceps (C) obtained after eight weeks of treatment groups GT(), GT50 (), GT150 () and GT500 (). Vertical columns and bars represent mean and standard deviation, respectively (n = 8). *p≤ GT vs. GT150; GT vs. GT500; #p ≤ 0.05; GT50 vs. GT150; GT50 vs. GT500; †p < 0.01; GT150 vs. GT500.